Related Experiment Video
Updated: Oct 28, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Pediatric morphea state-of-the-art literature review: Reframing morphea as a systemic disease
Jacquelyn R Sink1, Yvonne E Chiu2
1Department of Dermatology, Northwestern Medicine Regional Medical Group, Winfield, IL, USA.
Abstract:
Pediatric morphea is an inflammatory, fibrosing dermatologic disorder. Although morphea may be localized to the skin and subcutaneous tissues, differentiating it from systemic sclerosis, there is increasing evidence that morphea is a manifestation of a systemic inflammatory process, with the potential to involve many organ systems. Given the potential risk for irreversible sequelae, pediatric morphea should be treated early and aggressively. Long-term disease monitoring is essential.
Insights
Pediatric morphea, an inflammatory skin condition, may indicate a wider systemic inflammatory process. Early, aggressive treatment and long-term monitoring are crucial for managing this condition in children.
Area of Science:
- Dermatology
- Rheumatology
- Pediatrics
Background:
- Pediatric morphea is an inflammatory and fibrosing skin disorder.
- While often localized, evidence suggests it can be a manifestation of systemic inflammation.
- Morphea has the potential to affect multiple organ systems.
Purpose of the Study:
- To highlight the systemic nature of pediatric morphea.
- To emphasize the importance of early and aggressive treatment.
- To underscore the necessity of long-term disease monitoring.
Main Methods:
- This is a review and synthesis of current evidence regarding pediatric morphea.
- The abstract does not detail specific experimental methods.
Main Results:
- Increasing evidence indicates morphea is a systemic inflammatory process.
- The condition carries a risk for irreversible sequelae.
Conclusions:
- Pediatric morphea requires early and aggressive treatment.
- Long-term monitoring is essential for managing potential systemic involvement and sequelae.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism

